MicroRNAs (miRNAs) are small noncoding RNAs of about 20 nucleotides in length and participate in the posttranscriptional regulation of gene expression. Accumulating evidence indicates that miRNA binds to 3′ -UTR of its target mRNAs and thereby destabilizes the transcripts or suppresses the translation. It is expected that miRNAs could have diverse functions and therefore play a role in the gene expression caused by the drug treatment, which have yet to be determined. Demonstration of the participation of speciˆc miRNA in the drug-mediated gene expression would make it a biomarker for the toxicological assessment and help an understanding of molecular machinery of the drug-drug interaction. Under these backgrounds, we investigated the change of miRNAs in the liver of mice treated with phenobarbital, a typical inducer for drug-metabolizing enzymes, and demonstrate the participation of miRNAs in the phenobarbitalregulated gene expression. We investigated the relationship between phenobarbital-mediated changes in miRNA and mRNA by using Agilent miRNA microarray and DNA microarray, followed by real time RT-PCR. From these experiments, it was suggested that the phenobarbital-induced changes in cyp2c29 and mrp3 are regulated by miR-30a and miR29b, respectively. In addition, we obtained evidence that indicates a phenobarbital-mediated decrease in miR-122, a highly abundant liver-speciˆc miRNA, leads to the activation of the transcription factor CAR and thereby induces drugmetabolizing enzymes. 
Transporters and drug metabolizing enzymes encoded genes, which were induced or suppressed more than 2 fold in the mouse liver either 12, 24, or 48 h after PB-treatment (100 mg/kg, i.p.), are summarized. Open and shaded cells indicate up and down regulated genes, respectively. Comprehensive analysis of miRNA was carried out using miRNA microarray. Vertical and horizontal axes indicate log 2 (fold-change) and time after PB treatment, respectively. miRNAs changed by PB were extracted by the following conditions: the fold-change value was more than 1.3 and steady-state levels might be detected by real time RT-PCR. These miRNA are summarized in the right-hand table. Reporter plasmds were constructed by inserting the putative target sequence for either miR-30a resided in cyp2c29 3′ -UTR or miR-29b in mrp3 3′ -UTR downstream to the luciferase gene of the pGL3 promoter vector. Mice were transfected in vivo either with mrp3/miR-29b or cyp2c29/miR-30a reporter plasmid (9 mg) along with phRL-TK (1 mg) 24 h (A and C) or 12 h (B and D) before sacriˆce. When determined the eŠect of miRNA mimic (A and C) on the reporter, mice were also transfected either with negative control, miR-30a (A) or miR-29b (C) mimic RNAs (25 mg) at the same time to the transfection of reporter plasmid. PB was injected (100 mg/kg, i.p.) times as indicated before sacriˆce. Liver specimens were homogenized and subjected to the dual-luciferase assay. Fire‰y luciferase activity was normalized with respective Renilla luciferase activity and represents the mean±S.E. (A and C, n＝3; B, n＝8; D, n＝5) .  p＜0.05,   p＜0.01 (Student's t-test). 
